These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neopterin serum levels in pancreatic adenocarcinoma. Manes G, Spada OA, Rabitti PG, Feola B, Misso S, Minerva A, Uomo G. Int J Pancreatol; 1999 Feb; 25(1):31-7. PubMed ID: 10211419 [Abstract] [Full Text] [Related]
3. Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy. Wang Z, Dong M, Chu H, He J. Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1067-70. PubMed ID: 15488124 [Abstract] [Full Text] [Related]
4. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Grüngreiff K, Reinhold D, Ansorge S. Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433 [Abstract] [Full Text] [Related]
5. Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia. Amirghofran Z, Asiaee E, Kamazani FM. Asia Pac J Clin Oncol; 2016 Sep; 12(3):e375-82. PubMed ID: 25227983 [Abstract] [Full Text] [Related]
6. [Prognostic value of molecular biologogy and immunologic parameters in human pancreatic carcinoma]. Gansauge F, Gansauge S, Müller J, Schmid E, Beger HG. Langenbecks Arch Chir Suppl Kongressbd; 1998 Sep; 115(Suppl I):69-72. PubMed ID: 14518215 [Abstract] [Full Text] [Related]
7. Serum levels of neopterin and interleukin-2 receptor in women with severe preeclampsia. Kaleli I, Kaleli B, Demir M, Yildirim B, Cevahir N, Demir S. J Clin Lab Anal; 2005 Sep; 19(2):36-9. PubMed ID: 15756710 [Abstract] [Full Text] [Related]
8. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6. Weg-Remers S, Hildebrandt U, Feifel G, Moser C, Zeitz M, Stallmach A. Am J Gastroenterol; 1998 May; 93(5):790-4. PubMed ID: 9625129 [Abstract] [Full Text] [Related]
9. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma. Gansauge F, Gansauge S, Rau B, Scheiblich A, Poch B, Schoenberg MH, Beger HG. Cancer; 1997 Nov 01; 80(9):1733-9. PubMed ID: 9351541 [Abstract] [Full Text] [Related]
14. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Hidvégi B, Nagy E, Szabó T, Temesvári E, Marschalkó M, Kárpáti S, Horváth A, Gergely P. Int Arch Allergy Immunol; 2003 Oct 01; 132(2):177-82. PubMed ID: 14600430 [Abstract] [Full Text] [Related]
15. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2. Lissoni P, Tisi E, Brivio F, Barni S, Rovelli F, Perego M, Tancini G. Eur J Cancer; 1991 Oct 01; 27(8):1014-6. PubMed ID: 1832885 [Abstract] [Full Text] [Related]
16. Evaluation of systemic inflammatory response in cardiovascular surgery via interleukin-6, interleukin-8, and neopterin. Uyar IS, Onal S, Uysal A, Ozdemir U, Burma O, Bulut V. Heart Surg Forum; 2014 Feb 01; 17(1):E13-7. PubMed ID: 24631985 [Abstract] [Full Text] [Related]
17. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis. Ott M, Demisch L, Engelhardt W, Fischer PA. J Neurol; 1993 Dec 01; 241(2):108-14. PubMed ID: 8138825 [Abstract] [Full Text] [Related]
18. Clinical significance of serum CD44 measurement in malignant lymphoma. Fukuda Y. Kurume Med J; 2001 Dec 01; 48(1):65-9. PubMed ID: 11402623 [Abstract] [Full Text] [Related]
19. Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitis. Piecuch J, Rudzki M, Orkisz W, Swietochowska E, Wielkoszyński T, Waniczek D, Arendt J, Sosada K, Zurawiński W, Ładny JR. Hepatogastroenterology; 2008 Dec 01; 55(81):258-61. PubMed ID: 18507120 [Abstract] [Full Text] [Related]
20. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Saito H, Tsujitani S, Katano K, Ikeguchi M, Maeta M, Kaibara N. Cancer; 1998 Sep 15; 83(6):1094-101. PubMed ID: 9740073 [Abstract] [Full Text] [Related] Page: [Next] [New Search]